Skin Cancer Channel
Topics
Medications
Quicklinks
Related Channels

Sylatron Medication Information

SylatronTM (peginterferon alfa-2b) is licensed to help delay the regrowth of malignant melanoma (a type of skin cancer) after it has been surgically removed. It is a weekly injection that is given just under the skin (subcutaneously). This drug comes in three strengths and is currently sold as a brand-name product only. Your particular dosage will depend on factors such as your weight and how you respond to the medication.
 
Sylatron is not suitable for everyone, so make sure to review the medication's safety information with your healthcare provider before starting treatment. You may not be able to use this medicine if you have certain allergies or if you are taking certain other drugs. Also, let your healthcare provider know if you have diabetes, thyroid problems, depression, or any other medical conditions.
 
(For more information on this medication, click Sylatron. This Web selection provides a complete overview of this medicine, including how long treatment usually lasts, details on safety and effectiveness, possible side effects, and more.)
 

Sylatron Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.